Gene · 1459
CSNK2A2: casein kinase 2 alpha 2
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. CSNK2A2: casein kinase 2 alpha 2. Genes, record 1459. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1459
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P19784 | Casein kinase II subunit alpha' | 350 | 56 | Ensembl, GeneID, HGNC |
Source UniProt
Patents42
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 2082 | P19784 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1645 | P19784 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1645 | P19784 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2082 | P19784 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 12132 | P19784 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 5296 | P19784 | Espacenet |
| EP 4403581 A1 | 2024-07-24 | 4 | P19784 | Espacenet |
| WO 2023190820 A | 2023-10-05 | 4 | P19784 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 12132 | P19784 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 115103 | P19784 | Espacenet |
1 to 10 of 42
See all 42 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,555
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CSNK2A2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 15 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P30CA077598 | Cancer Center Support Grant | 7 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 5 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 4 | 2025 |
| P30CA043703 | Case Comprehensive Cancer Center Support Grant | 4 | 2025 |
| R01EY013431 | Mechanisms of epithelial alterations in diabetic cornea | 4 | 2025 |
| R01NS110694 | Molecular mechanisms of synaptic dysfunction and cognitive decline in Huntington's disease | 4 | 2025 |
| T32AI007051 | Immunologic Diseases and Basic Immunology | 4 | 2025 |
1 to 10 of 1,555Source NIH's project files
See all 1,555 nih grantsPapers2,405
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Broadening the Okur-Chung syndrome phenotype: adult-onset metabolic features and a contiguous 20p13 deletion in a Turkish multicenter cohort. | J Hum Genet | 2026 | 42706398 | PubTator, text mining | PubMed |
| NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling. | Exp Mol Med | 2026 | 42686986 | PubTator, text mining | PubMed |
| CSNK2A2 drives knee osteoarthritis progression by co-activating the Wnt/β-catenin and NF-κB signaling pathways. | Arch Biochem Biophys | 2026 | 42674201 | PubTator, text mining | PubMed |
| RAGE phosphorylation by CK2 in human epithelial cell model: Modulation of connexin 43 expression. | iScience | 2026 | 42621156 | PubTator, text mining | PubMed |
| Ambient PM2.5 exposure and sleep quality: Evidence from circadian DNA methylation signatures in a population-based study. | J Hazard Mater | 2026 | 42537304 | PubTator, text mining | PubMed |
| Discovery and characterization of a novel class of cyclic peptidic compounds inhibiting the subunit interaction of the protein kinase CK2α2β2 holoenzyme. | RSC Chem Biol | 2026 | 42433702 | PubTator, text mining | PubMed |
| FLOWR.ROOT - A flow matching-based foundation model for joint multi-purpose structure-aware 3D ligand generation and affinity prediction. | Nat Commun | 2026 | 42409794 | PubTator, text mining | PubMed |
| Blocking CK2α-Bclaf1 Preserves Oligodendrocytes After Neonatal Hypoxic Injury. | Glia | 2026 | 42388009 | PubTator, text mining | PubMed |
| Improved prognostic survival models for pediatric medulloblastoma using high dimensional gene expression data. | BMC Med Genomics | 2026 | 42387537 | PubTator, text mining | PubMed |
| Spatial Confinement-Accelerated DNAzyme Nanoassembly for Demethylase Imaging and Chemoresistance Evaluation in Living Cells. | ACS Nano | 2026 | 42361124 | PubTator, text mining | PubMed |
1 to 10 of 2,405
See all 2,405 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1459
GET https://conductscience.org/api/genes/v1/1459/patents?page=2